FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

Nichi-Iko Picks Up Sagent Pharmaceuticals

July 18, 2016
A A

Nichi-Iko Pharmaceutical has entered into an agreement to acquire Sagent Pharmaceuticals for nearly $736 million.

The acquisition combines Nichi-Iko’s biosimilar portfolio and Sagent’s line of injectables.

Currently, no operational changes are expected for Sagent Pharmaceuticals. — Anisa Jibrell 

View today's stories